pharma news today glp-1 obesity drugs What is the pipeline for future medications for obesity? GLP-1 Medications for Obesity: New
Description
Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RA) have shown promising effects on heart failure (HF) outcomes, particularly in phenotype-specific populations
At La Jolla Recovery, we integrate the latest neuroscience into our treatment approach because we know that recovery is not one-size-fits-all
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER As an observational study rather than a controlled clinical trial, it could not definitively prove that the genetic variants caused the difference in weight loss, only that they are associated with it, the researchers noted
Indeed, mRNA transcripts of the GLP-1R have been detected in the heart of rodents (185, 186) and humans (187)
